PLoS ONE, 2014 · DOI: 10.1371/journal.pone.0113368 · Published: December 29, 2014
This study investigated a new therapy called sono-electro-magnetic therapy for men with chronic pelvic pain syndrome (CPPS) that hasn't responded to other treatments. The study compared this new therapy to a placebo (inactive treatment) to see if it could reduce symptoms. The results showed that the therapy didn't significantly improve symptoms in the overall group, but a subgroup of men with shorter symptom duration (less than 12 months) seemed to benefit.
A larger trial of similar design is required to confirm or refute our preliminary results, particularly in patients with symptom duration of 12 months or less.
The significant interaction with duration of symptoms suggests that patients should be treated early in the course of the disease.
There are as yet no treatment standards for neuromodulation therapy, and no guidelines for therapeutic and maintenance regimens, and these must be developed through further research and testing.